AUG 17, 2026 · PHASE 2 TRIAL
Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK
ClinicalTrials.gov
This is a Phase 2 interventional trial registration with no results posted; the study is still recruiting and outcome data are not yet available.
Reported
Planned enrollment61
PhasePhase 2
Primary outcome measurePathological complete response (pCR) in pri…